PLN and type 2 diabetes mellitus: There is evidence to suggest a dysregulation of PLN/SERCA2a activity in the obese and/or T2D heart that may promote diastolic dysfunction and HFpEF, with many models observing a decrease in SERCA2a activity and altered calcium handling; however, the potential mechanisms of this dysregulation have varied and/or remained unclear.